Quiz: Treatments for presbyopia coming soon

Publication
Poll
Optometry Times JournalNovember digital edition 2020
Volume 12
Issue 11

quick quiz

This quiz accompanies THIS article from our November issue

1. What is the prevalence of presbyopia in the U.S.?

a. 5,000,000
b. 10,500,000
c. 50,000,000
d. 110,000,000

2. Miotics have few side effects.

a. True
b. False

3. Which of these devices uses pinhole optics (PHO)?

Revision Raindrop
b. Karama Inlay
c. FOV Tears
d. Allergan Presbysol
e. B and D

4. Which of these is not a pharmaco-refractive product?

a. Oraisis CSF-1
b. Presbyopia Therapies PRX-100
c. Allergan AGN
d. Eyenovia Micro-dose
e. All are pharmaco-refractive

5. What is the most common ingredient in current pharmaceutical drops for presbyopia being tested?

a. Dexamethasone
b. Pilocarpine
c. Bromfenac
d. Tropicamide
e. None of the above

6. Which of these is a device?

a. Oraisis CSF-1
b. Presbyopia Therapies PRX-100
c. Allergan AGN
d. Eyenovia Micro-dose
e. FOV Tears

Which is an active ingredient in PRX-100?

a. Pilocarpine
b. Tropicamide
c. Oxymetazoline
d. Polyethylene glycol
e. Diclofenac

Click here to see the correct answers

This quiz accompanies THIS article from our November issue

Articles in this issue
Quiz: Treatments for presbyopia coming soon
Quiz: Treatments for presbyopia coming soon
Quiz Answers: Treatments for presbyopia coming soon
Quiz Answers: Treatments for presbyopia coming soon
When to lease and when to own office space
When to lease and when to own office space
Vision rehabilitation of patients with stroke
Vision rehabilitation of patients with stroke
Treatments for presbyopia coming soon
Treatments for presbyopia coming soon
How diabetes affects COVID-19
How diabetes affects COVID-19

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Another drop in the presbyopia bucket: Dr Bloomenstein shares his excitement for the FDA approval of Vizz
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Related Content
Laboratory desk Image credit: AdobeStock/Shutter2U

Monthly pipeline update: A July news roundup

Jordana Joy, Associate Editor
August 8th 2025
Article
Optometry Times You and Eye

You and Eye: Undergoing EVO ICL vision correction as an eye care professional - with Jessica Vaidya, OD

Miriam Korik, OD;Jessica Vaidya, OD;Emily Kaiser Maharjan, Assistant Managing Editor
August 8th 2025
Podcast
Graphic displaying light entering the lens Image credit: EssilorLuxottica

Essilor announces release of new progressive lens to improve vision comfort for presbyopes

Jordana Joy, Associate Editor
August 8th 2025
Article
Podcast: Visus presbyopia drop gets FDA IND OK

Podcast: Visus presbyopia drop gets FDA IND OK

Rhett Schiffman, MD, MHSA;Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director;Brooke Henson, Editor
August 8th 2025
Podcast
Moderator Scot Morris at the AOA Innovation Hub at Optometry's Meeting 2025

AOA 2025: Innovation Hub sparks thoughtful conversations about AI, technology in eye care

Emily Kaiser Maharjan, Assistant Managing Editor
August 8th 2025
Article
Intraocular lens in dispensing system Image credit: AdobeStock/Oktay

Alcon's Clareon PanOptix Pro IOL now available in Canada

Jordana Joy, Associate Editor
August 8th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.